التفاصيل البيبلوغرافية
| العنوان: |
Biological activity of the bryostatin analog Merle 23 on mouse epidermal cells and mouse skin |
| المؤلفون: |
Gary E. Keck, Michelle A. Herrmann, Jin-Qiu Chen, Stuart H. Yuspa, Peter M. Blumberg, Mark E. Petersen, David O. Baumann, Jessica S. Kelsey, Christophe Cataisson, Kevin M. McGowan |
| المصدر: |
Molecular Carcinogenesis. 55:2183-2195 |
| بيانات النشر: |
Wiley, 2016. |
| سنة النشر: |
2016 |
| مصطلحات موضوعية: |
0301 basic medicine, Cancer Research, medicine.medical_specialty, Bryostatin 1, Epidermis (botany), Biological activity, Hyperplasia, Biology, 010402 general chemistry, medicine.disease, 01 natural sciences, 0104 chemical sciences, 03 medical and health sciences, chemistry.chemical_compound, 030104 developmental biology, Endocrinology, chemistry, Internal medicine, Phorbol, medicine, Cancer research, Tumor promotion, Bryostatin, Molecular Biology, Protein kinase C |
| الوصف: |
Bryostatin 1, a complex macrocyclic lactone, is the subject of multiple clinical trials for cancer chemotherapy. Although bryostatin 1 biochemically functions like the classic mouse skin tumor promoter phorbol 12-myristate 13-acetate (PMA) to bind to and activate protein kinase C, paradoxically, it fails to induce many of the typical phorbol ester responses, including tumor promotion. Intense synthetic efforts are currently underway to develop simplified bryostatin analogs that preserve the critical functional features of bryostatin 1, including its lack of tumor promoting activity. The degree to which bryostatin analogs maintain the unique pattern of biological behavior of bryostatin 1 depends on the specific cellular system and the specific response. Merle 23 is a significantly simplified bryostatin analog that retains bryostatin like activity only to a limited extent. Here, we show that in mouse epidermal cells the activity of Merle 23 was either similar to bryostatin 1 or intermediate between bryostatin 1 and PMA, depending on the specific parameter examined. We then examined the hyperplastic and tumor promoting activity of Merle 23 on mouse skin. Merle 23 showed substantially reduced hyperplasia and was not tumor promoting at a dose comparable to that for PMA. These results suggest that there may be substantial flexibility in the design of bryostatin analogs that retain its lack of tumor promoting activity. © 2016 Wiley Periodicals, Inc. |
| تدمد: |
0899-1987 |
| URL الوصول: |
https://explore.openaire.eu/search/publication?articleId=doi_________::1cf21fdb97208f40efb8a23f346bf97b
https://doi.org/10.1002/mc.22460 |
| حقوق: |
OPEN |
| رقم الأكسشن: |
edsair.doi...........1cf21fdb97208f40efb8a23f346bf97b |
| قاعدة البيانات: |
OpenAIRE |
